(844) 297-8423
(844) CYSTIC-FIBROSIS
Select Page

Kalydeco: A Homerun For CF

The FDA has approved KalydecoTM (ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis (CF), a rare, genetic disease. Kalydeco is approved for people with CF ages 6 and older who have at least one copy of the G551D mutation in the cystic...
Page 3 of 3123